Antibodies, Antiphospholipid
"Antibodies, Antiphospholipid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
Descriptor ID |
D017152
|
MeSH Number(s) |
D12.776.124.486.485.114.323.210 D12.776.124.790.651.114.323.210 D12.776.377.715.548.114.323.210
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Antiphospholipid".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Antiphospholipid".
This graph shows the total number of publications written about "Antibodies, Antiphospholipid" by people in this website by year, and whether "Antibodies, Antiphospholipid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 4 | 0 | 4 |
1998 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 2 | 3 |
2021 | 0 | 5 | 5 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Antiphospholipid" by people in Profiles.
-
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. Neurology. 2022 11 22; 99(21):e2368-e2377.
-
Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome. Circ Res. 2021 09 17; 129(7):735-750.
-
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19. J Thromb Haemost. 2021 09; 19(9):2335-2347.
-
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset. Lupus. 2021 Jul; 30(8):1283-1288.
-
Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science. 2021 03 12; 371(6534).
-
Letter by Almallouhi and Al Kasab Regarding Article, "Antiphospholipid Antibody and Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis". Stroke. 2021 01; 52(2):e68.
-
Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis. Blood. 2019 10 03; 134(14):1119-1131.
-
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 09; 71(9):1400-1412.
-
Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors. Thromb Haemost. 2019 Jul; 119(7):1147-1153.
-
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Adv. 2018 05 08; 2(9):979-986.